🇪🇺 PALIPERIDONE in European Union

PALIPERIDONE (PALIPERIDONE) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/005486
  • Local brand name: Byannli (previously Paliperidone Janssen-Cilag International)
  • Status: approved

PALIPERIDONE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PALIPERIDONE approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for PALIPERIDONE in European Union?

Marketing authorisation holder not available in our data.